Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
